Fundraising FoxBeacon Biosciences
Boston, US · Founded 2019 · 11 known investors
Find your way into Beacon Biosciences
Sign up to see every warm intro you have to Beacon Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Beacon Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Beacon Biosignals develops AI-powered EEG analytics technology to improve diagnosis and treatment of neurological, psychiatric, and sleep disorders. The company combines machine learning with neuroscience domain expertise to accelerate innovation for biopharma partners and clinical research organizations.
Founders & leadership
Beacon Biosciences was founded in 2019 by Jacob A. Donoghue, M.D., Ph.D., Jacob Donoghue, and Jarrett Revels.
Board
Investors · 11
.png)
How we know: General Catalyst's portfolio page · the company's own site · offering press articles · prnewswire.com · funding news · Not right? Tell us
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Kicker Ventures's portfolio page · Not right? Tell us
How we know: funding news · samsungnext.com · Not right? Tell us
How we know: offering press articles · press coverage · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$133.2M disclosed across 3 of 5 rounds · 2019–2026
- Undisclosed amountSeries CJun 2026Source ↗
▶$103.3MraisedApr 2026 · 43 investors · Other TechnologyRule 506(b)
- Caitlin DonovanDirector
- Pavel RaifeldDirector
- Jacob A. Donoghue, M.D., Ph.D.Executive Officer, Director
- Jarrett RevelsExecutive Officer
- Naveen RaoDirector
- Offering amount
- $103.3M
- Amount sold
- $103.3M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedOct 2021 · 42 investors · Other TechnologyRule 506(b)
- Naveen RaoDirector
- Jacob A. DonoghueExecutive Officer, Director
- Jarrett RevelsExecutive Officer
- Offering amount
- $29.9M
- Amount sold
- $29.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$50KraisedFeb 2019 · 1 investors · Other TechnologyRule 506(b)
- Jacob A. DonoghueExecutive Officer, Director, Promoter
- Naveen RaoDirector
- Jarrett RevelsExecutive Officer, Promoter
- Offering amount
- $1.6M
- Amount sold
- $50K
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Beacon Biosciences do?
- Beacon Biosignals develops AI-powered EEG analytics technology to improve diagnosis and treatment of neurological, psychiatric, and sleep disorders. The company combines machine learning with neuroscience domain expertise to accelerate innovation for biopharma partners and clinical research organizations.
- Who founded Beacon Biosciences?
- Beacon Biosciences was founded by Jacob A. Donoghue, M.D., Ph.D., Jacob Donoghue, Jarrett Revels in 2019.
- Who are Beacon Biosciences's investors?
- Beacon Biosciences's investors include General Catalyst, Alumni Ventures, Catalio Capital Management, LP, GV (Google Ventures), Iaso Ventures, Irregular Expressions, Kicker Ventures, Samsung Next and 3 more.
- How much funding has Beacon Biosciences raised?
- Beacon Biosciences has disclosed $133.2M raised across 3 of its 5 known rounds.
- Where is Beacon Biosciences headquartered?
- Beacon Biosciences is headquartered in Boston, US.